Effects of treatment with ambrisentan in patients with systemic sclerosis and mild pulmonary arterial hypertension: long-term follow-up data from EDITA study.

Autor: Uesbeck, P, Benjamin, N, Xanthouli, P, Egenlauf, B, Grünig, E, Harutyunova, S, Eichstaedt, C, Lorenz, H
Zdroj: Pneumologie; 2024 Supplement 1, Vol. 78, pS54-S54, 1p
Databáze: Complementary Index